MDGL CIK: 1157601

Madrigal Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−184
FY22:
−225
FY23:
−324
FY24:
−456
FY25:
−190
Change from FY21 to FY25
millions USD
FY21:
−5.06
FY22:
207
FY23:
−503
FY24:
−274
FY25:
32.3
Change from FY21 to FY25
millions USD
FY21:
171
FY22:
313
FY23:
595
FY24:
735
FY25:
256
millions USD
FY21:
−17.7
FY22:
295
FY23:
−232
FY24:
5.10
FY25:
98.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−184
FY22:
−225
FY23:
−326
FY24:
−457
FY25:
−190

All amounts in millions USD Data source:SEC EDGAR